0001209191-19-037341.txt : 20190617
0001209191-19-037341.hdr.sgml : 20190617
20190617123157
ACCESSION NUMBER: 0001209191-19-037341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190613
FILED AS OF DATE: 20190617
DATE AS OF CHANGE: 20190617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WORLAND STEPHEN T
CENTRAL INDEX KEY: 0001283307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36818
FILM NUMBER: 19900897
MAIL ADDRESS:
STREET 1: 9050 CAMINO SANTA FE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tracon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001394319
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4350 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 800
CITY: San Diego
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-550-0780
MAIL ADDRESS:
STREET 1: 4350 LA JOLLA VILLAGE DRIVE
STREET 2: SUITE 800
CITY: San Diego
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: Tracon Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070324
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-13
0
0001394319
Tracon Pharmaceuticals, Inc.
TCON
0001283307
WORLAND STEPHEN T
4350 LA JOLLA VILLAGE DRIVE
SUITE 800
SAN DIEGO
CA
92122
1
0
0
0
Director Stock Option (Right to Buy)
0.635
2019-06-13
4
A
0
15000
0.00
A
2029-06-12
Common Stock
15000
15000
D
The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders.
/s/ Scott B. Brown, Attorney-In-Fact
2019-06-17